AIMOVIG vs BREZTRI AEROSPHERE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. AIMOVIG and BREZTRI AEROSPHERE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	BREZTRI AEROSPHERE
Rating	72/100	New
Pharmacy pays	—	$0.75 /mL
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	BUDESONIDE AND FORMOTEROL FUMARATE AND GLYCOPYRROLATE
Manufacturer	Amgen Inc	Astrazeneca Ab
Dosage forms	Injectable, Solution	Spray/Inhaler, metered
Drug class	—	—
Boxed warning	None	None
Half-life	—	about 2 to 3.6 hours (terminal elimination half-life, measured after intravenous dosing)

aimovig breztri aerosphere

Rating

72/100

New

Pharmacy pays

—

$0.75 /mL

Type

Active ingredient

ERENUMAB-AOOE

BUDESONIDE AND FORMOTEROL FUMARATE AND GLYCOPYRROLATE

Manufacturer

Amgen Inc

Astrazeneca Ab

Dosage forms

Injectable, Solution

Spray/Inhaler, metered

Drug class

—

Boxed warning

None

Half-life

—

about 2 to 3.6 hours (terminal elimination half-life, measured after intravenous dosing)

Frequently asked questions

What is the difference between Aimovig and Breztri Aerosphere?

Aimovig contains Erenumab-Aooe, while Breztri Aerosphere contains Budesonide and Formoterol Fumarate and Glycopyrrolate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.